Internal Medicine, Hematology & Oncology · Morgantown, WV
NPI
1568898591
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1 Medical Center Dr
Morgantown, WV, 26506
Phone (855) 988-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
344 services
Medicare patients, 2024
104
Average age 72
Drug cost, 2024
$2.2M
703 prescriptions
Company payments, 2025
$4,902
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Salah Ud Din Safi was code 99214 (office e&m - established), 73 times for 44 patients. In total Salah Ud Din Safi billed 344 services in 28 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 73 | 44 | $65.25 | $4,763 |
| 99232 Hospital E&M - Subsequent | Facility | 69 | 18 | $63.44 | $4,377 |
| 99233 Hospital E&M - Subsequent | Facility | 51 | 20 | $95.53 | $4,872 |
| 99215 Office E&M - Established | Facility | 42 | 20 | $109.46 | $4,597 |
| 99238 Hospital Discharge Management | Facility | 18 | 15 | $64.57 | $1,162 |
| 99205 Office E&M - New | Facility | 18 | 18 | $139.30 | $2,507 |
| 99223 Hospital E&M - Initial | Facility | 16 | 14 | $134.40 | $2,150 |
By year: 2022 $18K for 231 services; 2023 $45K for 600 services; 2024 $27K for 344 services.
Medicare prescription drug claims, 2024
In 2024, the drug Salah Ud Din Safi prescribed most often to Medicare patients was Acyclovir, with 117 prescriptions and refills. In total Salah Ud Din Safi wrote 703 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 117 | 173 | 27 | $1,496 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 48 | 49 | Under 11 | $230 |
| Ondansetron Hcl Generic | 34 | 34 | 15 | $250 |
| Brukinsa Zanubrutinib | 31 | 31 | Under 11 | $463K |
| Eliquis Apixaban | 31 | 33 | Under 11 | $19K |
| Sprycel Dasatinib | 29 | 29 | Under 11 | $369K |
| Valacyclovir Valacyclovir Hcl | 26 | 30 | Under 11 | $448 |
| Prednisone Generic | 21 | 21 | Under 11 | $77.49 |
| Prochlorperazine Maleate Generic | 20 | 20 | 11 | $387 |
| Imatinib Mesylate Generic | 20 | 20 | Under 11 | $12K |
| Lenalidomide Generic | 17 | 17 | Under 11 | $188K |
| Levofloxacin Generic | 17 | 17 | Under 11 | $102 |
| Venclexta Venetoclax | 16 | 16 | Under 11 | $58K |
| Famotidine Generic | 16 | 18 | Under 11 | $97.31 |
| Gabapentin Generic | 16 | 16 | Under 11 | $159 |
Brand drugs: 187 claims; generic drugs: 516 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salah Ud Din Safi $4,902 ($4,902 in general payments such as food, travel and fees) from 6 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $4,775.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.